Mon, May 2, 2022
Sun, May 1, 2022
Fri, April 29, 2022
Thu, April 28, 2022

Gary Nachman Maintained (ALNY) at Hold with Decreased Target to $166 on, Apr 29th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-166-on-apr-29th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Gary Nachman of BMO Capital, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Decreased Target from $171 to $166 on, Apr 29th, 2022.

Gary has made no other calls on ALNY in the last 4 months.



There are 3 other peers that have a rating on ALNY. Out of the 3 peers that are also analyzing ALNY, 0 agree with Gary's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Gary


  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $400 on, Tuesday, April 12th, 2022
  • Etzer Darout of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $170 on, Thursday, February 3rd, 2022
  • Edward Tenthoff of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $208 on, Monday, January 3rd, 2022

Publication Contributing Sources